|
PRME
|
Prime Medicine, Inc.
|
US
|
NASDAQ
|
|
PSNL
|
Personalis, Inc.
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
US
|
NASDAQ
|
|
SIOX
|
Sio Gene Therapies Inc.
|
US
|
NASDAQ
|
|
SMFR
|
Sema4 Holdings Corp.
|
US
|
NASDAQ
|
|
TNGX
|
Tango Therapeutics
|
US
|
NASDAQ
|
|
TRDA
|
Entrada Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
US
|
NASDAQ
|
|
WVE
|
WAVE Life Sciences Ltd.
|
US
|
NASDAQ
|
|
GTG
|
Genetic Technologies Limited
|
AU
|
ASX
|
|
BIOGF
|
Biocartis Group NV
|
US
|
OTC
|
|
EPGNF
|
Epigenomics Ag Berli
|
US
|
OTC
|
|
GNTLF
|
Genetic Technologies Ltd
|
US
|
OTC
|
|
OXBDF
|
Oxford Biomedical Lt
|
US
|
OTC
|
|
PRED
|
Predictive Technology Group Inc
|
US
|
OTC
|
|
SLDX
|
Stella Diagnostics Inc
|
US
|
OTC
|
|
SZLSF
|
Stagezero Life Sciences Ltd
|
US
|
OTC
|
|
GDR
|
Genedrive Plc
|
UK
|
LSE
|
|
GENI
|
GENinCode plc
|
UK
|
LSE
|
|
IDHC
|
Integrated Diagnostics H
|
UK
|
LSE
|